Patricia Ashton-Prolla
Patricia Ashton-Prolla
Universidade Federal do Rio Grande do Sul, Hospital de Clinicas de Porto Alegre
بريد إلكتروني تم التحقق منه على hcpa.edu.br
عنوان
عدد مرات الاقتباسات
عدد مرات الاقتباسات
السنة
The TP53 mutation, R337H, is associated with Li-Fraumeni and Li-Fraumeni-like syndromes in Brazilian families
MIW Achatz, M Olivier, F Le Calvez, G Martel-Planche, A Lopes, BM Rossi, ...
Cancer letters 245 (1-2), 96-102, 2007
1862007
Fabry disease: twenty-two novel mutations in the alpha-galactosidase A gene and genotype/phenotype correlations in severely and mildly affected hemizygotes and heterozygotes.
P Ashton-Prolla, B Tong, J Shabbeer, KH Astrin, CM Eng, RJ Desnick
Journal of investigative medicine: the official publication of the American …, 2000
1532000
Thalidomide, a current teratogen in South America
EE Castilla, P Ashton‐Prolla, E Barreda‐Mejia, D Brunoni, DP Cavalcanti, ...
Teratology 54 (6), 273-277, 1996
1371996
Detailed haplotype analysis at the TP53 locus in p.R337H mutation carriers in the population of Southern Brazil: evidence for a founder effect
S Garritano, F Gemignani, EI Palmero, M Olivier, G Martel‐Planche, ...
Human mutation 31 (2), 143-150, 2010
1242010
Tumor protein 53 mutations and inherited cancer: beyond Li-Fraumeni syndrome
EI Palmero, MIW Achatz, P Ashton-Prolla, M Olivier, P Hainaut
Current opinion in oncology 22 (1), 64-69, 2010
1022010
Detection of R337H, a germline TP53 mutation predisposing to multiple cancers, in asymptomatic women participating in a breast cancer screening program in Southern Brazil
EI Palmero, L Schüler-Faccini, M Caleffi, MIW Achatz, M Olivier, ...
Cancer letters 261 (1), 21-25, 2008
1022008
An alternative protocol for DNA extraction from formalin fixed and paraffin wax embedded tissue
R Coura, JC Prolla, L Meurer, P Ashton-Prolla
Journal of Clinical Pathology 58 (8), 894-895, 2005
1012005
Pregnancy outcome after exposure to misoprostol in Brazil: a prospective, controlled study
L Schüler, A Pastuszak, MTV Sanseverino, IM Orioliz, D Brunoni, ...
Reproductive Toxicology 13 (2), 147-151, 1999
961999
Genomic rearrangements in BRCA1 and BRCA2: a literature review
IP Ewald, PLI Ribeiro, EI Palmero, SL Cossio, R Giugliani, ...
Genetics and Molecular Biology 32 (3), 437-446, 2009
892009
Impact of β1-adrenergic receptor polymorphisms on susceptibility to heart failure, arrhythmogenesis, prognosis, and response to beta-blocker therapy
A Biolo, N Clausell, KG Santos, R Salvaro, P Ashton-Prolla, A Borges, ...
The American journal of cardiology 102 (6), 726-732, 2008
812008
Development and validation of a simple questionnaire for the identification of hereditary breast cancer in primary care
P Ashton-Prolla, J Giacomazzi, AV Schmidt, FL Roth, EI Palmero, ...
BMC cancer 9 (1), 283, 2009
732009
TP53 PIN3 and MDM2 SNP309 polymorphisms as genetic modifiers in the Li–Fraumeni syndrome: impact on age at first diagnosis
V Marcel, EI Palmero, P Falagan-Lotsch, G Martel-Planche, ...
Journal of medical genetics 46 (11), 766-772, 2009
732009
BDNF/TrkB content and interaction with gastrin-releasing peptide receptor blockade in colorectal cancer
CB De Farias, DB Rosemberg, TE Heinen, P Koehler-Santos, ...
Oncology 79 (5-6), 430-439, 2010
62*2010
Highly prevalent TP53 mutation predisposing to many cancers in the Brazilian population: a case for newborn screening?
MIW Achatz, P Hainaut, P Ashton-Prolla
The lancet oncology 10 (9), 920-925, 2009
612009
TSC1 and TSC2 gene mutations and their implications for treatment in Tuberous Sclerosis Complex: a review
C Rosset, CBO Netto, P Ashton-Prolla
Genetics and molecular biology 40 (1), 69-79, 2017
592017
Reviewing the history of HIV-1: spread of subtype B in the Americas
DM Junqueira, RM De Medeiros, MCC Matte, LAL Araújo, JAB Chies, ...
PloS one 6 (11), e27489, 2011
542011
PRIMA-1, a mutant p53 reactivator, induces apoptosis and enhances chemotherapeutic cytotoxicity in pancreatic cancer cell lines
P Izetti, A Hautefeuille, AL Abujamra, CB de Farias, J Giacomazzi, ...
Investigational new drugs 32 (5), 783-794, 2014
522014
A model to optimize public health care and downstage breast cancer in limited-resource populations in southern Brazil.(Porto Alegre Breast Health Intervention Cohort)
M Caleffi, RA Ribeiro, DL Duarte Filho, P Ashton-Prolla, AJ Bedin, ...
BMC public health 9 (1), 1-8, 2009
472009
miRNA-21 and miRNA-34a are potential minimally invasive biomarkers for the diagnosis of pancreatic ductal adenocarcinoma
B Alemar, P Izetti, C Gregório, GS Macedo, MAA Castro, AB Osvaldt, ...
Pancreas 45 (1), 84-92, 2016
462016
Non–pseudogene-derived complex acid β-glucosidase mutations causing mild type 1 and severe type 2 Gaucher disease
ME Grace, P Ashton-Prolla, GM Pastores, A Soni, RJ Desnick
The Journal of clinical investigation 103 (6), 817-823, 1999
461999
يتعذر على النظام إجراء العملية في الوقت الحالي. عاود المحاولة لاحقًا.
مقالات 1–20